ProCE Banner Activity

Why I Recommend Drug Resistance Testing Prior to Long-Acting Injectable ART Initiation

Clinical Thought

For people living with HIV who are interested in LA injectable ART, here’s why we need a complete and extensive review of prior antiretroviral therapy and resistance testing to best inform and enhance shared decision-making.

Released: July 18, 2023

Share

Faculty

Amanda Binkley

Amanda Binkley, PharmD, BCIDP, AAHIVP

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
Penn Presbyterian Medical Center
Pennsylvania, Philadelphia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Disclosure

Primary Author

Amanda Binkley, PharmD, BCIDP, AAHIVP

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
Penn Presbyterian Medical Center
Pennsylvania, Philadelphia

Amanda Binkley, PharmD, BCIDP, AAHIVP: consultant/advisor/speaker: ViiV.